Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Urologic Diseases 1Shock 1Rheumatic Diseases 1Renal Insufficiency 1Nervous System Diseases 1Kidney Diseases 1Infections 1Hematologic Diseases 1Heart Failure 1Gastrointestinal Diseases 1Critical Illness 1Cardiovascular Diseases 1Asthma 1Arrhythmias, Cardiac 1

Interventions

Standard of Care 2Rituximab 2Carvedilol 2sacubitril and valsartan sodium hydrate drug combination 1pegfilgrastim 1obinutuzumab 1empagliflozin 1dapagliflozin 1acalabrutinib 1Vincristine 1Vascular Stiffness 1Valsartan 1Specimen Handling 1Pulse Wave Analysis 1Prednisolone 1Practice Guidelines as Topic 1Palliative Care 1Nutrition Assessment 1Mesenchymal Stem Cell Transplantation 1Lenalidomide 1Health Information Exchange 1Exercise 1Eplerenone 1Electronic Health Records 1Electrocardiography 1Echocardiography 1Doxorubicin 1Dexrazoxane 1Cyclophosphamide 1Cardiac Resynchronization Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Heart Failure × Health Information Exchange × 1 year × Clear all
NCT05443321 2026-01-23

Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes

Brigham and Women's Hospital

Phase NA Enrolling by invitation
1,006 enrolled
GastrointestinalGenitourinary

Arrhythmias, Cardiac, Asthma, Cardiovascular Diseases, Gastrointestinal Diseases, Heart Failure, Hematologic Diseases, Infections, Kidney Diseases, Nervous System Diseases, Rheumatic Diseases, Shock, Urologic Diseases, Critical Illness, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡